Stockscreener 앱 받기
0.148
2.99%
0.0043
전일 마감가:
$0.1437
열려 있는:
$0.1477
하루 거래량:
692.76K
Relative Volume:
0.07
시가총액:
$3.77M
수익:
$357.90K
순이익/손실:
$-11.06M
주가수익비율:
-0.1321
EPS:
-1.1201
순현금흐름:
$-11.90M
1주 성능:
-25.67%
1개월 성능:
-29.52%
6개월 성능:
-31.92%
1년 성능:
-90.92%
1일 변동 폭
$0.144
$0.15
1주일 범위
$0.1425
$0.2099
52주 변동 폭
$0.1425
$1.73
Biorestorative Therapies Inc Stock (BRTX) Company Profile
명칭
Biorestorative Therapies Inc
전화
(631) 760-8100
주소
40 MARCUS DRIVE, MELVILLE
Compare BRTX vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BRTX
Biorestorative Therapies Inc
|
0.148 | 5.62M | 357.90K | -11.06M | -11.90M | -1.1201 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Biorestorative Therapies Inc 주식(BRTX)의 최신 뉴스
BioRestorative Therapies Halts ExoCR and BioX Shipments - TipRanks
BioRestorative Therapies Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
MSN Money - MSN
BioRestorative Therapies (NASDAQ:BRTX): Why Is Cell-Therapy Development And Manufacturing Readiness in Focus Today? - Kalkine Media
BRTX Q2'26 Earnings: EPS estimate is (0.10) USD - TradingView
BioRestorative Therapies (BRTX) Holds Near $0.23 as Modest Gains Build on Thin VolumeFundamentals - dars.gov.et
Form 8K BioRestorative Therapies Inc For: 14 August By Investing.com - Investing.com Nigeria
BioRestorative Therapies suspends shipments of ExoCR and BioX products for review - Investing.com
BioRestorative Therapies Delays Quarterly SEC Filing - TipRanks
Biorestorative Therapies Suspends All Orders, Shipments Of Exocr, Biox Biocosmeceutical Product Lines Effective Immediately, On Aug 7 - TradingView
BioRestorative Therapies (BRTX) delays Q2 10-Q amid losses and going-concern risk - Stock Titan
BioRestorative Therapies, Inc. Suspends All Orders And Shipments Of Biocosmeceutical Product Lines - marketscreener.com
BRTX Q2'26 Earnings: revenue estimate is 600.00K USD - TradingView
BRTX Q1 2026 Earnings: Narrower-Than-Expected Loss Delivers 41% EPS SurpriseRevenue Guidance Update - vinanet.vn
BioRestorative Therapies Inc (BRTX) Stock News Today - TradingKey
BioRestorative Therapies (BRTX) Edges Lower, Holds $0.20 Support as Price Action TightensSupply Zone - vinanet.vn
BioRestorative Therapies (BRTX) investor Alta Partners reports 4.99% ownership cap - Stock Titan
BRTX Q1 2026 Earnings: Loss Beats Estimates by 41.18% While Shares Fall 9.22%Revenue Recognition Risk - vinanet.vn
BioRestorative Therapies (BRTX) reports director Esha Randhawa’s insider status - Stock Titan
BioRestorative Therapies Inc - TradingKey
BioRestorative Therapies Inc (BRTX) Balance Sheet - TradingKey
BioRestorative Therapies Inc (BRTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BioRestorative Therapies Inc (BRTX) Valuation: PE, PB & Fair Value Analysis - TradingKey
BioRestorative Therapies Inc (BRTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BioRestorative Therapies Inc (BRTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BRTX|BioRestorative Therapies Inc|Price:0.219|Chg%:+0.018 - TradingKey
BioRestorative Therapies Inc (BRTX) Cash Flow - TradingKey
BioRestorative Therapies Inc (BRTX) Income Statement - tradingkey.com
BRTX|BioRestorative Therapies Inc|Price:0.270|Chg%:-0.007 - TradingKey
BioRestorative Therapies Inc (BRTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BRTX|BioRestorative Therapies Inc|Price:0.282|Chg%:-0.008 - TradingKey
BRTX|BioRestorative Therapies Inc|Price:0.226|Chg%:+0.006 - TradingKey
BioRestorative Therapies (BRTX) Slides 7% – Testing Critical Support at $0.28Institutional Sentiment - vinanet.vn
BioRestorative Therapies, Inc. Revenue Breakdown – GETTEX:9OF - TradingView
BRTX Q1 2026 Earnings: Narrower Loss Exceeds Expectations Amid Pipeline ProgressEarnings Yield Analysis - vinanet.vn
Biorestorative Therapies Company Profile & Introduction - Moomoo
BRTX Q1 2026 Earnings: EPS Surpasses Estimates Despite No Revenue, Stock SlipsForward EPS Estimate - vinanet.vn
BioRestorative Therapies (BRTX) Q1 2026 Earnings: Narrower Loss Beats Estimates as Company Advances PipelineAnnual Financial Report - dars.gov.et
BioRestorative Therapies Announces Amendments to Executive Employment Agreements in July 2026 - Minichart
Leadership shake-up at Biorestorative Therapies (NASDAQ: BRTX) and new CEO - Stock Titan
BioRestorative Therapies, Inc. Announces CFO Changes, Effective July 13, 2026 - marketscreener.com
BRTX Q1 2026 Earnings: EPS Surpasses Estimates Despite No RevenuePerformance Review - vinanet.vn
BioRestorative Therapies (BRTX) Holds Steady Near Support Zone Amid Quiet TradingDynamic Hedging - dars.gov.et
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX) - AOL.com
Price to book forward of BioRestorative Therapies, Inc. – GETTEX:9OF - TradingView
BioRestorative Therapies (BRTX) Slides 1% to $0.40, Tests Key Support Amid Low VolumeWyckoff Upthrust - dars.gov.et
BRTX Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Cost Discipline Amid Clinical Progress - dars.gov.et
Here's why Biorestorative Therapies (BRTX) looks ripe for bottom fishing - MSN
BioRestorative Therapies, Inc.'s Equity Buyback announced on August 12, 2025, has expired. - marketscreener.com
BioRestorative Therapies (BRTX) Rises 1.62% as Stock Holds Above Key Support at $0.36Volatility Stop - DonanımHaber
Biorestorative Therapies Inc (BRTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
0.31%
자본화:
|
볼륨(24시간):